» Articles » PMID: 22709616

Effects of Group Metacognitive Training (MCT) on Mental Capacity and Functioning in Patients with Psychosis in a Secure Forensic Psychiatric Hospital: a Prospective-cohort Waiting List Controlled Study

Overview
Journal BMC Res Notes
Publisher Biomed Central
Date 2012 Jun 20
PMID 22709616
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Metacognitive Training (MCT) is a manualised cognitive intervention for psychosis aimed at transferring knowledge of cognitive biases and providing corrective experiences. The aim of MCT is to facilitate symptom reduction and protect against relapse. In a naturalistic audit of clinical effectiveness we examined what effect group MCT has on mental capacity, symptoms of psychosis and global function in patients with a psychotic illness, when compared with a waiting list comparison group.

Methods: Of 93 patients detained in a forensic mental health hospital under both forensic and civil mental health legislation, 19 were assessed as suitable for MCT and 11 commenced. These were compared with 8 waiting list patients also deemed suitable for group MCT who did not receive it in the study timeframe. The PANSS, GAF, MacArthur Competence Assessment Tool- Treatment (MacCAT-T) and MacArthur Competence Assessment Tool-Fitness to Plead (MacCAT-FP) were recorded at baseline and repeated after group MCT or following treatment as usual in the waiting list group.

Results: When baseline functioning was accounted for, patients that attended MCT improved in capacity to consent to treatment as assessed by the MacCAT-T (p = 0.019). The more sessions attended, the greater the improvements in capacity to consent to treatment, mainly due to improvement in MacCAT-T understanding (p = 0.014) and reasoning . The GAF score improved in patients who attended the MCT group when compared to the waiting list group (p = 0.038) but there were no changes in PANSS scores.

Conclusion: Measures of functional mental capacity and global function can be used as outcome measures for MCT. MCT can be used successfully even in psychotic patients detained in a forensic setting. The restoration of elements of decision making capacity such as understanding and reasoning may be a hither-to unrecognised advantage of such treatment. Because pharmacotherapy can be optimised and there is likely to be enough time to complete the course, there are clear opportunities to benefit from such treatment programmes in forensic settings.

Citing Articles

Treatment Decision-Making Capacity in Forensic vs Non-forensic Psychiatric Patients: A European Comparison.

Marazia C, Rucci P, Fangerau H, Vossberg D, Rolfes V, Iozzino L Schizophr Bull Open. 2024; 3(1):sgac037.

PMID: 39144784 PMC: 11205899. DOI: 10.1093/schizbullopen/sgac037.


Positive and negative syndrome scale in forensic patients with schizophrenia spectrum disorders: a systematic review and meta-analysis.

Buizza C, Strozza C, Sbravati G, de Girolamo G, Ferrari C, Iozzino L Ann Gen Psychiatry. 2022; 21(1):36.

PMID: 36088451 PMC: 9463849. DOI: 10.1186/s12991-022-00413-2.


Efficacy of metacognitive training on symptom severity, neurocognition and social cognition in patients with schizophrenia: A single-blind randomized controlled trial.

Fekete Z, Vass E, Balajthy R, Tana U, Nagy A, Olah B Scand J Psychol. 2022; 63(4):321-333.

PMID: 35388496 PMC: 9544200. DOI: 10.1111/sjop.12811.


Immediate and Sustained Outcomes and Moderators Associated With Metacognitive Training for Psychosis: A Systematic Review and Meta-analysis.

Penney D, Sauve G, Mendelson D, Thibaudeau E, Moritz S, Lepage M JAMA Psychiatry. 2022; 79(5):417-429.

PMID: 35320347 PMC: 8943641. DOI: 10.1001/jamapsychiatry.2022.0277.


Can metacognitive interventions improve insight in schizophrenia spectrum disorders? A systematic review and meta-analysis.

Lopez-Morinigo J, Ajnakina O, Martinez A, Escobedo-Aedo P, Ruiz-Ruano V, Sanchez-Alonso S Psychol Med. 2020; 50(14):2289-2301.

PMID: 33050956 PMC: 7610184. DOI: 10.1017/S0033291720003384.


References
1.
Bell V, Halligan P, Ellis H . Explaining delusions: a cognitive perspective. Trends Cogn Sci. 2006; 10(5):219-26. DOI: 10.1016/j.tics.2006.03.004. View

2.
Moritz S, Kerstan A, Veckenstedt R, Randjbar S, Vitzthum F, Schmidt C . Further evidence for the efficacy of a metacognitive group training in schizophrenia. Behav Res Ther. 2011; 49(3):151-7. DOI: 10.1016/j.brat.2010.11.010. View

3.
Pillay S, Oliver B, Butler L, Kennedy H . Risk stratification and the care pathway. Ir J Psychol Med. 2018; 25(4):123-127. DOI: 10.1017/S0790966700011228. View

4.
Aghotor J, Pfueller U, Moritz S, Weisbrod M, Roesch-Ely D . Metacognitive training for patients with schizophrenia (MCT): feasibility and preliminary evidence for its efficacy. J Behav Ther Exp Psychiatry. 2010; 41(3):207-11. DOI: 10.1016/j.jbtep.2010.01.004. View

5.
Wykes T, Steel C, Everitt B, Tarrier N . Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull. 2007; 34(3):523-37. PMC: 2632426. DOI: 10.1093/schbul/sbm114. View